Mukai S - Search Results

1

Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy?

Pennock S, Haddock LJ, Eliott D, Mukai S, Kazlauskas A. Pennock S, et al. Among authors: mukai s. Prog Retin Eye Res. 2014 May;40:16-34. doi: 10.1016/j.preteyeres.2013.12.006. Epub 2014 Jan 9. Prog Retin Eye Res. 2014. PMID: 24412519 Review.

2

Vascular endothelial growth factor acts primarily via platelet-derived growth factor receptor α to promote proliferative vitreoretinopathy.

Pennock S, Haddock LJ, Mukai S, Kazlauskas A. Pennock S, et al. Among authors: mukai s. Am J Pathol. 2014 Nov;184(11):3052-68. doi: 10.1016/j.ajpath.2014.07.026. Epub 2014 Sep 26. Am J Pathol. 2014. PMID: 25261788 Free PMC article.

3

RasGAP Promotes Autophagy and Thereby Suppresses Platelet-Derived Growth Factor Receptor-Mediated Signaling Events, Cellular Responses, and Pathology.

Lei H, Qian CX, Lei J, Haddock LJ, Mukai S, Kazlauskas A. Lei H, et al. Among authors: mukai s. Mol Cell Biol. 2015 May;35(10):1673-85. doi: 10.1128/MCB.01248-14. Epub 2015 Mar 2. Mol Cell Biol. 2015. PMID: 25733681 Free PMC article.

4

A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy.

Pennock S, Rheaume MA, Mukai S, Kazlauskas A. Pennock S, et al. Among authors: mukai s. Am J Pathol. 2011 Dec;179(6):2931-40. doi: 10.1016/j.ajpath.2011.08.043. Epub 2011 Oct 28. Am J Pathol. 2011. PMID: 22035642 Free PMC article.

5

Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Pennock S, Kim D, Mukai S, Kuhnle M, Chun DW, Matsubara J, Cui J, Ma P, Maberley D, Samad A, Van Geest RJ, Oberstein SL, Schlingemann RO, Kazlauskas A. Pennock S, et al. Among authors: mukai s. Am J Pathol. 2013 May;182(5):1659-70. doi: 10.1016/j.ajpath.2013.01.052. Epub 2013 Apr 9. Am J Pathol. 2013. PMID: 23582767 Free PMC article.

6

Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases.

Ma G, Duan Y, Huang X, Qian CX, Chee Y, Mukai S, Cui J, Samad A, Matsubara JA, Kazlauskas A, D'Amore PA, Gu S, Lei H. Ma G, et al. Among authors: mukai s. Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3935-43. doi: 10.1167/iovs.16-19405. Invest Ophthalmol Vis Sci. 2016. PMID: 27472081 Free PMC article.

7

Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells.

Lei H, Rhéaume MA, Velez G, Mukai S, Kazlauskas A. Lei H, et al. Among authors: mukai s. Invest Ophthalmol Vis Sci. 2011 Aug 24;52(9):5016-21. doi: 10.1167/iovs.11-7442. Invest Ophthalmol Vis Sci. 2011. PMID: 21642621 Free PMC article.

8

A novel function of p53: a gatekeeper of retinal detachment.

Lei H, Rheaume MA, Cui J, Mukai S, Maberley D, Samad A, Matsubara J, Kazlauskas A. Lei H, et al. Among authors: mukai s. Am J Pathol. 2012 Sep;181(3):866-74. doi: 10.1016/j.ajpath.2012.05.036. Am J Pathol. 2012. PMID: 22901751 Free PMC article.

9

Simple, inexpensive technique for high-quality smartphone fundus photography in human and animal eyes.

Haddock LJ, Kim DY, Mukai S. Haddock LJ, et al. Among authors: mukai s. J Ophthalmol. 2013;2013:518479. doi: 10.1155/2013/518479. Epub 2013 Sep 19. J Ophthalmol. 2013. PMID: 24171108 Free PMC article.

10

PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis.

Wu W, Zhou G, Han H, Huang X, Jiang H, Mukai S, Kazlauskas A, Cui J, Matsubara JA, Vanhaesebroeck B, Xia X, Wang J, Lei H. Wu W, et al. Among authors: mukai s. Diabetes. 2020 Apr;69(4):736-748. doi: 10.2337/db19-0713. Epub 2020 Jan 8. Diabetes. 2020. PMID: 31915155 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

880 results

Search Page